Summary
Systemic micro RNA therapy has great future for liver cancer cancer. Small molecule probes as mRNA inhibitors will open new avenue for cancer therapy basically to liver cancer.
Analysis
This in-vivo efficacy data has a great promise in RNA therapy and that is to cancer.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
